Status:
COMPLETED
Scleroderma Patient-centered Intervention Network (SPIN) Hand Program
Lead Sponsor:
Lady Davis Institute
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
The Arthritis Society, Canada
Conditions:
Scleroderma
Systemic Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Scleroderma Patient-centered Intervention Network (SPIN) is an organization established by researchers, health care providers, and people living with scleroderma (systemic sclerosis or SSc) from C...
Detailed Description
For individuals with SSc, skin and tendon involvement of the hands with significant functional impairment is nearly universal. Hand function limitations impact disability more than any other aspect of...
Eligibility Criteria
Inclusion
- SPIN Cohort inclusion criteria:
- A SSc diagnosis based on 2013 American College of Rheumatology/European League Against Rheumatism criteria confirmed by a SPIN physician
- Be ≥18 years old, be able to give informed consent
- Be fluent in English or French.
- For SPIN-HAND:
- At least mild hand function limitations (Cochin Hand Function Scale (CHFS) ≥ 3)
- Have indicated high interest in using an online hand exercise intervention (≥6 on 0-10 scale) and indicated willingness to participate in a trial of the SPIN-HAND program (yes/no)
Exclusion
- Participants not able to access or respond to questionnaires via the internet are excluded
- Participants randomized to the intervention group in the SPIN-HAND feasibility study are excluded
Key Trial Info
Start Date :
March 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2020
Estimated Enrollment :
466 Patients enrolled
Trial Details
Trial ID
NCT03419208
Start Date
March 12 2018
End Date
May 30 2020
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jewish General Hospital
Montreal, Quebec, Canada, H3S 1Y9